However, the precise role of EGFR and ERBBs alone or in crosstalk with other oncoproteins or transmembrane receptors in the development and progression of CC has remained largely unknown and unclear compared with those of other cancer types. This evidence concerns the gene NRP1 and cholangiocarcinoma.